logo
King Charles' Cancer Is Incurable, Bombshell Report Suggests

King Charles' Cancer Is Incurable, Bombshell Report Suggests

Yahoo3 days ago

King Charles' will die 'with' but not 'of' cancer, a bombshell report claimed Saturday.
The report essentially confirms long-standing rumors that the king's cancer is considered manageable but ultimately incurable, which is the case for many older individuals afflicted by the disease.
Charles is 76.
The report will be unwelcome in the palace, as it will reignite speculation that the king's health is in a delicate state, rumors that were rekindled when Prince Harry said in a recent BBC interview that he didn't know how long his father had left to live.
Charles' aides have consistently briefed reporters that he is, broadly speaking, winning his battle against cancer, and the king himself recently said he was on 'the other side' of the health crisis.
The king is back to essentially running a full diary after being diagnosed with cancer last year, albeit with some modifications.
The report, by the respected royal writer and associate editor of the U.K. Daily Telegraph, Camilla Tominey, also claimed that Charles will never move into Buckingham Palace due to his health struggles.
'The talk now is that he may die 'with' cancer, but not 'of' cancer following a rigorous treatment program,' she wrote.
A spokesperson for the king declined to comment.
Tominey, who was the first to break the news about Prince Harry and Meghan dating and also about the latter's row with Kate Middleton, added that planning for Charles' 80th birthday in 2028, while 'very tentative,' is going ahead.
Tominey also claimed that Charles and Harry could be publicly reunited at the Invictus Games, in Birmingham in 2027, with palace aides quietly investigating whether the event could provide a suitable backdrop for a long-awaited reconciliation.
It is understood officials hope any reconciliation would include Prince Archie and Princess Lilibet. The king last saw the children in 2022. Harry has said he can't bring his family safely to the U.K. and hinted some powerful palace figures want him dead.
Intriguingly, Tominey suggests that a reconciliation might be considered because of the negative impact the narrative of estrangement is having on the king's reputation.
She writes: 'There is an awareness that the impasse cannot continue forever, not least if it starts to reflect badly on the king.'
Prince Harry said, in a bitter interview with the BBC following a comprehensive legal defeat on his security arrangements, that he does not know how long his cancer-hit father has left to live because the king won't speak to him.
Harry also said he won't bring his family to the U.K., blamed his father for his security being reduced after leaving the royal family, and said he had 'forgiven' those family members who had hurt him.
He added, 'Some members of my family will never forgive me for writing a book but I would love reconciliation with my family.'
The prince continued, 'There is a lot of control and ability in my father's hands. Ultimately, this whole thing could be resolved through him.'
Appearing emotional, Harry said, ​'There's no point in continuing to fight anymore. As I said, life is precious. I don't know how much longer my father has. He won't speak to me because of this security stuff, but it would be nice to reconcile.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

This Hilarious Prime Video Caper Flips the Script on British Crime Drama
This Hilarious Prime Video Caper Flips the Script on British Crime Drama

CNET

timean hour ago

  • CNET

This Hilarious Prime Video Caper Flips the Script on British Crime Drama

You can't move for hit British crime shows right now. Whether it's Dept. Q or Adolescence on Netflix; MobLand on Paramount Plus; or Slow Horses on Apple TV Plus (even if that one's technically more of a spy show), gritty and binge-worthy content is showing up on the best streaming services, all delivered in a vibrant array of British accents. Deep Cover feels like a real crowd-pleaser. Peter Mountain/Metronome Film But a shift is happening. We're about to enter cozy-crime summer, when the genre will get an injection of lighthearted comedy, largely thanks to the much-anticipated adaptation of Richard Osman's Thursday Murder Club book series, set to land on Netflix this August. In the meantime, Prime Video is getting in there first with Deep Cover -- an action-comedy that flips the British crime script from serious to silly in the best possible way. In the film, which arrives on Prime Video on June 12, an unlikely trio of improv actors, all of differing skill levels, is recruited as undercover police officers and infiltrates London's underworld, theoretically to bust a drug ring. Needless to say, am-dram chaos ensues. Bryce Dallas Howard plays a failed stand-up comic turned improv teacher who ropes her two most hapless students into the gang: a method actor with delusions of grandeur, played by Orlando Bloom, and a nervy IT office nerd, played by Nick Mohammed. Together the three, nicknaming themselves Bonnie, Roach and the Squire, fudge their way through meetings with gangland bosses, each more intimidating than the next, and somehow manage to find friendship and romance along the way. I went to the film's premiere at SXSW London last week and came away convinced that Deep Cover should be at the top of everyone's watch list this weekend. The combination of comedy and action lands it squarely in crowd-pleaser territory, somewhere between Hot Fuzz and The Fall Guy. Of Deep Cover's three stars, it's Mohammed who has the most established comedy chops and gets the biggest laughs (you'll likely know him best as Nathan Shelley in Ted Lasso -- the kit man who defects to become a rival coach). That's not to say Bloom, who steps somewhat out of his comfort zone in this role, and Howard don't also deliver. The chemistry between the three lead characters keeps you rooting for them long after their "yes, and..." improv approach to undercover work seems to be failing them. The film's director, Tom Kingsley, has also worked on the Bafta-winning TV show Stath Lets Flats (available on Max), which is simultaneously the most Greek and most British piece of television you could ever hope to watch, and which I've long been convinced is a work of significant comic genius. Deep Cover has the same echoes of awkward, almost farcical humor, but with an Amazon-size budget behind it. Still, as Kingsley explained during a Q&A following the premiere, the budget was far smaller than anyone might expect for such a production. Bringing in bona fide Hollywood stars Bloom and Johnson attracted more funding, as did Amazon hopping on board. But the film was reportedly made on something of a shoestring by Hollywood standards. Still, it's easy to see where the injection of cash ended up. Deep Cover's action scenes are sometimes outlandishly slapstick, perfectly befitting of the three clowns at their center, and at times so graphic or high octane that they don't always jell with the overall tenor of the film. It's a minor niggle in the scheme of things, and one that shouldn't deter you. For all its silliness and stunts, Deep Cover is ultimately a heartwarming tale about developing adult friendships at that stage in life when you might feel like the moments for such opportunities have passed. If you're looking for something easy and fun to watch this weekend, then look no further.

FDA Approves New 3-in-1 Combo Pill for High Blood Pressure
FDA Approves New 3-in-1 Combo Pill for High Blood Pressure

WebMD

time3 hours ago

  • WebMD

FDA Approves New 3-in-1 Combo Pill for High Blood Pressure

June 11, 2025 – The FDA has approved a new pill for adults with high blood pressure (hypertension) that combines three medicines in one. Available in one regular and two lower doses, it offers a convenient option for treating hypertension, which affects nearly half of the adults in the U.S. and raises their risk of stroke and heart failure. Sold as Widaplik, it is the first and only single pill to combine three previously FDA-approved drugs – telmisartan, amlodipine, and indapamide – offering a triple-action approach for people who would otherwise need multiple pills to manage their blood pressure. It works in three ways and is a safe, well-tolerated early treatment option. Hypertension happens when your blood pushes too hard against your blood vessels, making the heart work harder and increasing the risk of heart problems, strokes, and other complications. It contributes to about 460,000 deaths annually in the U.S. and often goes undetected due to a lack of symptoms. With 1 in 3 Americans unaware they have it and only 1 in 4 managing it well, there's an urgent need for simpler, more effective treatments. The approval was based on two large studies that showed using Widaplik helped lower blood pressure more than using just two medicines or a placebo, according to a news release from the company that makes it, George Medicines. People who took Widaplik didn't stop taking it more often because of side effects, which means it was generally easy for them to take. Another trial showed that Widaplik was better at reducing blood pressure compared to standard care, while remaining well-tolerated. George Medicines stated that a global trial is underway to find out if the combo treatment can help prevent strokes in people who have previously had an intracerebral hemorrhage (sudden bleeding in the brain), the most serious type of stroke. "Single-pill combination antihypertensive therapy has great potential to improve hypertension control in the US and worldwide. Most patients with hypertension need multiple therapies to achieve their blood pressure goals. The new dose options available with Widaplik offer a treatment regimen that could benefit a broad range of patients, including those just starting treatment," Paul Whelton, MD, Show Chwan chair of global public health at Tulane University in New Orleans and past president of the World Hypertension League, said in a statement. Widaplik is a medicine made of three drugs that work together to help lower blood pressure. Two of them, telmisartan and amlodipine, relax blood vessels so blood can flow more easily. The third, indapamide, helps your body get rid of extra water by making you pee more. Widaplik comes in three strengths: 10/1.25/0.625 mg, 20/2.5/1.25 mg, and 40/5/2.5 mg. Low blood pressure – which can make you feel faint or dizzy – was the most common side effect, the company said. Patients who pass out should stop taking the medication and consult their doctor.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store